Sinha MS - Search Results

1

Fentanyl panic goes viral: The spread of misinformation about overdose risk from casual contact with fentanyl in mainstream and social media.

Beletsky L, Seymour S, Kang S, Siegel Z, Sinha MS, Marino R, Dave A, Freifeld C. Beletsky L, et al. Among authors: sinha ms. Int J Drug Policy. 2020 Sep 16;86:102951. doi: 10.1016/j.drugpo.2020.102951. Online ahead of print. Int J Drug Policy. 2020. PMID: 32949901 Free PMC article.

2

Social Media Impact of the Food and Drug Administration's Drug Safety Communication Messaging About Zolpidem: Mixed-Methods Analysis.

Sinha MS, Freifeld CC, Brownstein JS, Donneyong MM, Rausch P, Lappin BM, Zhou EH, Dal Pan GJ, Pawar AM, Hwang TJ, Avorn J, Kesselheim AS. Sinha MS, et al. JMIR Public Health Surveill. 2018 Jan 5;4(1):e1. doi: 10.2196/publichealth.7823. JMIR Public Health Surveill. 2018. PMID: 29305342 Free PMC article.

3

Neither Ethical Nor Effective: The False Promise of Involuntary Commitment to Address the Overdose Crisis.

Sinha MS, Messinger JC, Beletsky L. Sinha MS, et al. J Law Med Ethics. 2020 Dec;48(4):741-743. doi: 10.1177/1073110520979384. J Law Med Ethics. 2020. PMID: 33404332 No abstract available.

4

Covid-19 - The Law and Limits of Quarantine.

Parmet WE, Sinha MS. Parmet WE, et al. Among authors: sinha ms. N Engl J Med. 2020 Apr 9;382(15):e28. doi: 10.1056/NEJMp2004211. Epub 2020 Mar 18. N Engl J Med. 2020. PMID: 32187460 No abstract available.

5

The Perils of Panic: Ebola, HIV, and the Intersection of Global Health and Law.

Sinha MS, Parmet WE. Sinha MS, et al. Am J Law Med. 2016 May;42(2-3):223-255. doi: 10.1177/0098858816658269. Am J Law Med. 2016. PMID: 29086642

6

Multimodal Analysis of FDA Drug Safety Communications: Lessons from Zolpidem.

Kesselheim AS, Sinha MS, Campbell EG, Schneeweiss S, Rausch P, Lappin BM, Zhou EH, Avorn J, Dal Pan GJ. Kesselheim AS, et al. Among authors: sinha ms. Drug Saf. 2019 Nov;42(11):1287-1295. doi: 10.1007/s40264-019-00849-8. Drug Saf. 2019. PMID: 31302895

7

Return to work during coronavirus disease 2019 (COVID-19): Temperature screening is no panacea.

Slade DH, Sinha MS. Slade DH, et al. Among authors: sinha ms. Infect Control Hosp Epidemiol. 2021 Sep;42(9):1166-1167. doi: 10.1017/ice.2020.1225. Epub 2020 Sep 23. Infect Control Hosp Epidemiol. 2021. PMID: 32962769 Free PMC article. No abstract available.

8

A Crisis-Responsive Framework for Medical Device Development Applied to the COVID-19 Pandemic.

Antonini MJ, Plana D, Srinivasan S, Atta L, Achanta A, Yang H, Cramer AK, Freake J, Sinha MS, Yu SH, LeBoeuf NR, Linville-Engler B, Sorger PK. Antonini MJ, et al. Among authors: sinha ms. Front Digit Health. 2021 Mar;3:617106. doi: 10.3389/fdgth.2021.617106. Epub 2021 Mar 22. Front Digit Health. 2021. PMID: 33899045 Free PMC article.

9

Prescription Opioid Epidemic and Trends in the Clinical Development of New Pain Medications.

Hwang TJ, Sinha MS, Dave CV, Kesselheim AS. Hwang TJ, et al. Among authors: sinha ms. Mayo Clin Proc. 2019 Dec;94(12):2437-2443. doi: 10.1016/j.mayocp.2019.05.015. Epub 2019 Nov 2. Mayo Clin Proc. 2019. PMID: 31685265

10

Antitrust, Market Exclusivity, and Transparency in the Pharmaceutical Industry.

Sinha MS, Curfman GD, Carrier MA. Sinha MS, et al. JAMA. 2018 Jun 12;319(22):2271-2272. doi: 10.1001/jama.2018.3478. JAMA. 2018. PMID: 29801104 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters